Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes

OBJECTIVE: Diabetes has emerged as an important risk factor for mortality from COVID-19. Metformin, the most commonly prescribed glucose-lowering agent, has been proposed to influence susceptibility to and outcomes of COVID-19 via multiple mechanisms. We investigated whether, in patients with diabet...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Clin Endocrinol Metab
Κύριοι συγγραφείς: Wang, Jingya, Cooper, Jennifer M, Gokhale, Krishna, Acosta-Mena, Dionisio, Dhalla, Samir, Byne, Nathan, Chandan, Joht Singh, Anand, Astha, Okoth, Kelvin, Subramanian, Anuradhaa, Bangash, Mansoor N, Jackson, Thomas, Zemedikun, Dawit, Taverner, Tom, Hanif, Wasim, Ghosh, Sandip, Narendran, Parth, Toulis, Konstantinos A, Tahrani, Abd A, Surenthirakumaran, Rajendra, Adderley, Nicola J, Haroon, Shamil, Khunti, Kamlesh, Sainsbury, Christopher, Thomas, G Neil, Nirantharakumar, Krishnarajah
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2021
Θέματα:
Clinical Research Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928949/
https://ncbi.nlm.nih.gov/pubmed/33560344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab067
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια